Sort by

Send to

Choose Destination

Links from PubMed

Items: 17


Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor.

Karmakar S, Gao T, Pace MC, Oesterreich S, Smith CL.

Mol Endocrinol. 2010 Jun;24(6):1187-202. doi: 10.1210/me.2009-0480.


Cyclin dependent kinase 2 and the regulation of human progesterone receptor activity.

Moore NL, Narayanan R, Weigel NL.

Steroids. 2007 Feb;72(2):202-9. Review.


The role of SRC-3 in human breast cancer.

Gojis O, Rudraraju B, Gudi M, Hogben K, Sousha S, Coombes RC, Cleator S, Palmieri C.

Nat Rev Clin Oncol. 2010 Feb;7(2):83-9. doi: 10.1038/nrclinonc.2009.219. Review. Erratum in: Nat Rev Clin Oncol. 2010 Mar;7(3):122. Coombes, Charles R [corrected to Coombes, R Charles].


Steroid receptor coactivators: servants and masters for control of systems metabolism.

Stashi E, York B, O'Malley BW.

Trends Endocrinol Metab. 2014 Jul;25(7):337-47. doi: 10.1016/j.tem.2014.05.004. Review.


Emerging roles of the corepressors NCoR1 and SMRT in homeostasis.

Mottis A, Mouchiroud L, Auwerx J.

Genes Dev. 2013 Apr 15;27(8):819-35. doi: 10.1101/gad.214023.113. Review.


Minireview: the SRC family of coactivators: an entrée to understanding a subset of polygenic diseases?

Lonard DM, Kumar R, O'Malley BW.

Mol Endocrinol. 2010 Feb;24(2):279-85. doi: 10.1210/me.2009-0276. Review.


Minireview: steroid receptor coactivator-3: a multifarious coregulator in mammary gland metastasis.

Lydon JP, O'Malley BW.

Endocrinology. 2011 Jan;152(1):19-25. doi: 10.1210/en.2010-1012. Review.


Cdc25B as a steroid receptor coactivator.

Chua SS, Ma Z, Ngan E, Tsai SY.

Vitam Horm. 2004;68:231-56. Review.


Nuclear receptor corepressor complexes in cancer: mechanism, function and regulation.

Wong MM, Guo C, Zhang J.

Am J Clin Exp Urol. 2014 Oct 2;2(3):169-87. Review.


Steroid receptor coactivator 2 is required for female fertility and mammary morphogenesis: insights from the mouse, relevance to the human.

Mukherjee A, Amato P, Allred DC, DeMayo FJ, Lydon JP.

Nucl Recept Signal. 2007 Nov 30;5:e011. doi: 10.1621/nrs.05011. Review.


Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer.

Fowler AM, Clark AS, Katzenellenbogen JA, Linden HM, Dehdashti F.

J Nucl Med. 2016 Feb;57 Suppl 1:75S-80S. doi: 10.2967/jnumed.115.157933. Review.


Steroid receptor coactivators 1, 2, and 3: critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based cancer therapy.

Johnson AB, O'Malley BW.

Mol Cell Endocrinol. 2012 Jan 30;348(2):430-9. doi: 10.1016/j.mce.2011.04.021. Review.


TBL1XR1 in physiological and pathological states.

Li JY, Daniels G, Wang J, Zhang X.

Am J Clin Exp Urol. 2015 Apr 25;3(1):13-23. Review.


Steroid receptor coactivator-3 as a potential molecular target for cancer therapy.

Tien JC, Xu J.

Expert Opin Ther Targets. 2012 Nov;16(11):1085-96. doi: 10.1517/14728222.2012.718330. Review.


Steroid receptor RNA activator: Biologic function and role in disease.

Liu C, Wu HT, Zhu N, Shi YN, Liu Z, Ao BX, Liao DF, Zheng XL, Qin L.

Clin Chim Acta. 2016 Aug 1;459:137-46. doi: 10.1016/j.cca.2016.06.004. Review.


The Role of Steroid Receptor Coactivators in Hormone Dependent Cancers and Their Potential as Therapeutic Targets.

Wang L, Lonard DM, O'Malley BW.

Horm Cancer. 2016 Aug;7(4):229-35. doi: 10.1007/s12672-016-0261-6. Review.


Nuclear receptor coactivators: master regulators of human health and disease.

Dasgupta S, Lonard DM, O'Malley BW.

Annu Rev Med. 2014;65:279-92. doi: 10.1146/annurev-med-051812-145316. Review.

Items per page

Supplemental Content

Support Center